Displaying drugs 10776 - 10800 of 12591 in total
LY-294002
Specific inhibitor of phosphatidylinositol 3-kinase.
Experimental
Matched Description: … Specific inhibitor of phosphatidylinositol 3-kinase. …
Desfesoterodine
Desfesoterodine is a metabolite of tolterodine.
Experimental
Matched Description: … Desfesoterodine is a metabolite of [tolterodine]. …
Vonapanitase
Vonapanitase is under investigation for the treatment of Chronic Kidney Disease.
Investigational
Matched Description: … Vonapanitase is under investigation for the treatment of Chronic Kidney Disease. …
PF-04447943
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
VP-14637
MDT-637 has been investigated for the treatment of Drug Safety.
Investigational
Matched Description: … MDT-637 has been investigated for the treatment of Drug Safety. …
Tozadenant
Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational
Matched Description: … Tozadenant has been investigated for the basic science of Cocaine Dependence. …
BIIB021
BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
Investigational
Matched Description: … BIIB021 has been investigated for the treatment of Tumors and Lymphoma. …
Forigerimod
Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.
Investigational
Matched Description: … Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic. …
Combretastatin
Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Investigational
Matched Description: … Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer. …
Sisomicin
Sisomicin has been used in trials studying the treatment of Pyoderma.
Investigational
Matched Description: … Sisomicin has been used in trials studying the treatment of Pyoderma. …
Methyl isocyanate
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
Matched Description: … Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia. …
ZSTK-474
ZSTK474 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … ZSTK474 has been used in trials studying the treatment of Neoplasms. …
Gallopamil
Gallopamil has been used in trials studying the treatment of Asthma.
Investigational
Matched Description: … Gallopamil has been used in trials studying the treatment of Asthma. …
Triethylhexanoin
Triethylhexanoin is an ingredient of cosmetic products as a fragrant solvent.
Experimental
Matched Description: … Triethylhexanoin is an ingredient of cosmetic products as a fragrant solvent. …
CA-170
CA-170 is a selective, small molecule inhibitor of PD-L1.
Investigational
Matched Description: … CA-170 is a selective, small molecule inhibitor of PD-L1. …
Lecithin
A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.
Experimental
Matched Description: … A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines …
DMP-777
DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.
Investigational
Matched Description: … DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase. …
OSSM-007
OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells.
Investigational
Matched Description: … OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells. …
APL-030
APL-030 is a orally-active small molecule inhibitor of GCN2.
Investigational
Matched Description: … APL-030 is a orally-active small molecule inhibitor of GCN2. …
Dithioerythritol
A compound that, along with its isomer, Cleland's reagent (dithiothreitol), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups. [PubChem]
Experimental
Matched Description: … compound that, along with its isomer, Cleland's reagent (dithiothreitol), is used for the protection of ... sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl …
DDP-200
DDP200 is developed by Dynogen for the treatment of non-incontinent form of overactive bladder (OAB) with particular focus on both male and female patients with urinary frequency, urinary urgency and nocturia.
Investigational
Matched Description: … DDP200 is developed by Dynogen for the treatment of non-incontinent form of overactive bladder (OAB) …
Pafuramidine
Pafuramidine, a prodrug of furamidine, currently has orphan status for Pneumocystis jiroveci pneumonia.
Investigational
Matched Description: … Pafuramidine, a prodrug of furamidine, currently has orphan status for _Pneumocystis jiroveci_ pneumonia …
Omiganan
Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.
Investigational
Matched Description: … Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections. …
Henagliflozin
Henagliflozin has been used in trials studying the treatment of Type 2 Diabetes.
Investigational
Matched Description: … Henagliflozin has been used in trials studying the treatment of Type 2 Diabetes. …
Solnatide
Solnatide has been used in trials studying the treatment of Acute Lung Injury.
Investigational
Matched Description: … Solnatide has been used in trials studying the treatment of Acute Lung Injury. …
Displaying drugs 10776 - 10800 of 12591 in total